Zensun Sci & Tech, Ltd., a biopharmaceutical company based in Shanghai and San Diego, announced today positive results of four completed Phase 2 clinical trials including three double-blind, placebo-controlled studies conducted in China and Australia and interim results from the United States Phase 2 trial for Zensun’s innovative “first-in-class” anti-heart failure drug, Neucardin™.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61677-zensun-completes-clinical-trials-of-neucardin-treatment-of-heart-failure
A pill designed to zero in on abnormal genes that drive specific cancers has produced encouraging early results in children with an uncommon but aggressive type of lymphoma, as well as in children with a rare form of neuroblastoma.
A phase 1 clinical trial of the drug crizotinib achieved remissions, with minimal side effects, for 10 of the children participating in a clinical study carried out by the multicenter Children’s Oncology Group (COG). The results were “an exciting proof-of-principle” for the targeted treatment, said the study leader, Yaël P. Mossé, M.D., a pediatric oncologist at The Children’s Hospital of Philadelphia.
“We are entering a new era of cancer therapy, in which we use knowledge of basic biology to design very specific drugs that target cancer cells with potentially less side effects on healthy tissue,” said Mossé. “In addition, as we concentrate on targets in molecular pathways, we move away from an exclusive focus on one form of cancer to customizing treatments according to biological activity. Abnormal ALK activity occurs in subtypes of neuroblastoma and subtypes of lymphoma, so identifying ALK activity in individual patients may enable us to provide the most effective care.”
To view Multimedia News Release, go to http://www.multivu.com/mnr/50776-childrens-hospital-philadelphia-lymphoma-neuroblastoma-oncology-gene-trial
The winners of the Natural Light - International Design Competition have now been chosen from the 172 impressive Natural Light Lamp designs submitted from 65 countries around the world. The winners are two very talented Argentinian Industrial Design students, Ms. Mariana Arando and Mr. Luca Fondello, both from the University of Buenos Aires, Argentina. The production phase of the winning design for the Natural Light Lamp will begin shortly, followed next year by shipment of the lamps to three African countries without access to electricity.
Last year, the VELUX Group and Little Sun joined forces to launch the Natural Light – International Design Competition, which challenged design students around the world to create a design for a solar lamp which would help to bring clean, reliable, affordable light to some of the 1.2 billion people worldwide living without electricity. Now the jury has voted and decided on the winning solar lamp design by two Industrial Design students from the University of Buenos Aires in Argentina.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7533451-velux-winner-announcement-natural-light/
The winners of the Natural Light - International Design Competition have now been chosen from the 172 impressive Natural Light Lamp designs submitted from 65 countries around the world. The winners are two very talented Argentinian Industrial Design students, Ms. Mariana Arando and Mr. Luca Fondello, both from the University of Buenos Aires, Argentina. The production phase of the winning design for the Natural Light Lamp will begin shortly, followed next year by shipment of the lamps to three African countries without access to electricity.
Last year, the VELUX Group and Little Sun joined forces to launch the Natural Light – International Design Competition, which challenged design students around the world to create a design for a solar lamp which would help to bring clean, reliable, affordable light to some of the 1.2 billion people worldwide living without electricity. Now the jury has voted and decided on the winning solar lamp design by two Industrial Design students from the University of Buenos Aires in Argentina.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7533451-velux-winner-announcement-natural-light/
New entertainment integrations and social media initiatives move the “ugly truth” campaign into a new phase this month, further seeding important tobacco-related facts and messages with teens and young adults. The latest advertising campaign from truth – the nation’s largest youth smoking prevention campaign – features its first television ads since 2010, and a host of marketing and digital tools to educate and connect with teens and young people through a range of digital media initiatives and entertainment integrations.
To view Multimedia News Release, go to http://www.multivu.com/mnr/62254-truth-campaign-gets-uglier-entertainment-integrations-expand-conversation
West Pharmaceutical Services, Inc. (NYSE: WST) and HealthPrize Technologies, LLC, today announced the completion of the first two phases of their four-phase strategic collaboration. The companies are working to integrate HealthPrize’s Software-as-a-Service (SaaS) medication adherence and patient-engagement platform with West’s injectable drug delivery systems to provide an end-to-end connected health solution for pharmaceutical companies and the patients they serve. The combined offering will provide voluntary, electronically connected drug delivery systems that track when patients take their medication. The HealthPrize system engages and educates patients to increase adherence and medical literacy, rewarding interaction and compliance with prescribed treatment plans, and contributing to better health outcomes.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7625851-west-pharma-healthprize-tech-collaboration/
Volkswagen startet 30 Jahre nach seinem Markteintritt in China in eine Phase nachhaltigen Wachstums. Im Zuge des Ausbaus der Fertigungskapazitäten investieren die beiden chinesischen Joint-Ventures des Volkswagen Konzerns bis 2015 mehr als zwei Drittel von insgesamt 9,8 Milliarden Euro in hocheffiziente Produkte. Der für China zuständige Vorstand der Volkswagen Aktiengesellschaft Prof. Dr. Jochem Heizmann, präzisierte am Vortag der Auto Shanghai 2013 die auf den chinesischen Markt zugeschnittene Elektromobilitäts-Strategie. Es sei geplant, von 2014/2015 an Fahrzeuge mit elektrifiziertem Antrieb anzubieten, die zum Teil lokal produziert werden. Bereits 26 Modelle des Konzerns sind von staatlicher Seite als besonders energiesparend und umweltschonend anerkannt worden. Volkswagen habe den verbrauch seiner in China derzeit mehr als 70 Modelle umfassenden Flotte zwischen 2005 und 2010 um 20 Prozent reduziert und werde ihn bis 2015 um weitere 11 Prozent senken.
Taj Hotels Resorts & Palaces today announced the second phase of their brand architecture exercise with the roll-over of 19 hotels to their new brand, Vivanta by Taj Hotels & Resorts, slotted in the 5-Star Upper Upscale segment. India’s largest hospitality group flagged off Vivanta by Taj Hotels & Resorts at a gala event at the brand’s marquee hotel, Vivanta by Taj – Whitefield, Bangalore. This follows the highly successful launch of their Upscale brand - The Gateway Hotel - exactly two years ago.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/ihc/44198/
Online Registration Guidline
ACRI is specialized in providing Clinical Research Courses like Pg Diploma in clinical CDM and SAS course with guarantee internship in leading CRO’S & 100% Placement.
Reach us at:
Avigna Clinical Research Institute:-
No.33,3rd Floor,15th Cross,
2nd Phase,J.P.Nagar,100ft Ring Road,
Bangalore-560078
080-26588910 / 91-9741600499
http://www.acriindia.com
info@acriindia.com
On May 26, 2012, the 22 teams competing for the Solar Decathlon China 2013 made a group appearance to the public in the City of Datong, Shanxi Province, marking the successful close to the team selection process and the official start of the promotion phase.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56423-solar-decathlon-china-2013
Live Looping with an RC- 300, GR-20, Digitech Jamman, phase shifter, ambient reverb, tera echo, and a Boss Digital Delay. The RC - 300 is used to loop guitar all on separate loops/tracks, the pedals are used to create ambient and delayed sounds with the guitar.
Video by HouseTwelve Media (http://www.housetwelve.com/)
Subaru of America, Inc. today announced the completion of a Pet Travel Seat Pilot Study as part of its continued partnership with Center for Pet Safety (CPS), a registered 501(c)(3) non-profit research and consumer advocacy organization. Subaru and CPS have tested pet products most commonly used by pet parents when traveling. Phase one tested pet harnesses, phase two tested pet crates and carriers, and now, phase three has tested pet travel seats.
A pet travel seat is typically used in a vehicle to hold or elevate the pet, but does not offer full containment. The Pet Travel Seat Pilot Study found that while a pet travel seat may offer distraction prevention, it will likely not offer crash protection in the event of an accident, which could lead to injury of the pet and the human vehicle passengers. The quality of commonly available pet travel seats did not provide effective protection in a crash scenario.
Based on the scientific test evidence collected over the past four years, in part through its partnership with Subaru, CPS can now identify the safest travel options for most pets. For small dogs and cats, Center for Pet Safety recommends one of the 2015 Top Performing Carriers; for medium and large dogs either the 2015 Top Performing Crate - Gunner Kennels G1 Intermediate with 8' Tie Down Straps, or a Center for Pet Safety Certified Harness. To view top performing products and CPS Certified products, visit www.CenterforPetSafety.org.
To view the multimedia release go to:
http://www.multivu.com/players/English/7074158-subaru-cps-pet-travel-seat-study/
